Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.

Abstract

BACKGROUND:

Although dialysis ameliorates uremia and fluid and electrolytes disorders, annual mortality rate remains high in dialysis population reflecting its shortcoming in replacing renal function. Unlike the normal kidney, dialysis causes dramatic shifts in volume and composition of body fluids and indiscriminate removal of vital solutes. Present study was undertaken to determine the impact of hemodialysis on plasma metabolites in end-stage renal disease (ESRD) patients.

METHODS:

80 hemodialysis patients and 80 age/gender-matched healthy controls were enrolled in the study. Using ultra performance liquid chromatography-high-definition mass spectrometry, we measured plasma metabolites before, during, and after hemodialysis procedure and in blood entering and leaving the dialysis filter.

RESULTS:

Principal component analysis revealed significant difference in concentration of 214 metabolites between healthy control and ESRD patients' pre-dialysis plasma (126 increased and 88 reduced in ESRD group). Comparison of post-dialysis with pre-dialysis data revealed significant changes in the 362 metabolites. Among ESI+ metabolites 195 decreased and 55 increased and among ESI- metabolites 82 decreased and 30 increased following hemodialysis. Single blood passage through the dialyzer caused significant changes in 323 metabolites. Comparison of ESRD patients' post-hemodialysis with healthy subjects' data revealed marked differences in metabolic profiles. We identified 55 of the 362 differential metabolites including well known uremic toxins, waste products and vital biological compounds.

CONCLUSION:

In addition to uremic toxins and waste products hemodialysis removes large number of identified and as-yet un-identified metabolites. Depletion of vital biological compounds by dialysis may contribute to the high morbidity and annual mortality rate in this population.

• Authors: Zhi-Hao Zhang, Jia-Rong Mao, Hua Chen, Wei Su, Yuan Zhang, Li Zhang, Dan-Qian Chen, Ying-Yong Zhao, Nosratola D Vaziri
• Journal: Clinical biochemistry (Clin Biochem) Vol. 50 Issue 18 Pg. 1078-1086 (Dec 2017) ISSN: 1873-2933 [Electronic] United States
• PMID: 28928007 (Publication Type: Journal Article)
• Copyright: Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Topics

• Adult
• Aged
• Case-Control Studies
• Chromatography, High Pressure Liquid
• Female
• Humans
• Kidney Failure, Chronic (blood, metabolism)
• Male
• Metabolomics (methods)
• Middle Aged
• Renal Dialysis (adverse effects, methods)
• Renal Insufficiency, Chronic (complications)
• Uremia (blood)